MYGN: the balance sheet

MyFinsight

MYRIAD GENETICS INC (MYGN)

Balance Sheets	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Cash and cash equivalents	124,400	149,600	145,400	74,400
Trade accounts receivable	123,800	115,300	118,000	137,000
Inventory	27,900	30,600	31,600	28,700
Prepaid taxes	2,000	12,000	13,800	14,300
Prepaid expenses and other current assets	34,700	25,100	36,000	29,900
Total current assets	312,800	332,600	344,800	284,300
Operating lease right-of-use assets	51,000	49,400	50,600	51,200
Property, plant and equipment, net	111,500	114,000	111,400	113,000
Intangible assets, net	145,700	153,400	163,100	170,100
Goodwill	47,100	51,600	51,600	51,600
Other assets	5,600	5,600	6,600	7,100
Total assets	673,700	706,600	728,100	677,300

Current debt	NaN	NaN	NaN	59,400
Accounts payable	32,600	30,000	31,800	30,900
Accrued liabilities	90,500	96,900	108,300	100,600
Current maturities of operating lease liabilities	7,100	6,900	7,900	9,000
Total current liabilities	130,200	133,800	148,000	199,900
Unrecognized tax benefits	NaN	200	1,200	1,200
Long-term debt	120,300	119,900	119,500	0
Noncurrent operating lease liabilities	84,100	83,000	84,900	86,200
Other long-term liabilities	1,700	1,700	1,700	1,900
Total liabilities	336,300	338,600	355,300	289,200
Common stock, 94.4 and 93.5 shares outstanding at march31, 2026 and december31, 2025, respectively	900	900	900	900
Additional paid-in capital	1,492,600	1,489,000	1,486,800	1,474,700
Accumulated other comprehensive income	700	800	-100	-100
Accumulated deficit	-1,156,800	-1,122,700	-1,114,800	-1,087,400
Total stockholders' equity	337,400	368,000	372,800	388,100
Total liabilities and stockholders equity	673,700	706,600	728,100	677,300

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.